Suppr超能文献

南亚的疟疾:流行状况与防治。

Malaria in South Asia: prevalence and control.

机构信息

National Institute of Malaria Research, Panaji, Goa, India.

出版信息

Acta Trop. 2012 Mar;121(3):246-55. doi: 10.1016/j.actatropica.2012.01.004. Epub 2012 Jan 8.

Abstract

The "Malaria Evolution in South Asia" (MESA) program project is an International Center of Excellence for Malaria Research (ICEMR) sponsored by the US National Institutes of Health. This US-India collaborative program will study the origin of genetic diversity of malaria parasites and their selection on the Indian subcontinent. This knowledge should contribute to a better understanding of unexpected disease outbreaks and unpredictable disease presentations from Plasmodium falciparum and Plasmodium vivax infections. In this first of two reviews, we highlight malaria prevalence in India. In particular, we draw attention to variations in distribution of different human-parasites and different vectors, variation in drug resistance traits, and multiple forms of clinical presentations. Uneven malaria severity in India is often attributed to large discrepancies in health care accessibility as well as human migrations within the country and across neighboring borders. Poor access to health care goes hand in hand with poor reporting from some of the same areas, combining to possibly distort disease prevalence and death from malaria in some parts of India. Corrections are underway in the form of increased resources for disease control, greater engagement of village-level health workers for early diagnosis and treatment, and possibly new public-private partnerships activities accompanying traditional national malaria control programs in the most severely affected areas. A second accompanying review raises the possibility that, beyond uneven health care, evolutionary pressures may alter malaria parasites in ways that contribute to severe disease in India, particularly in the NE corridor of India bordering Myanmar Narayanasamy et al., 2012.

摘要

“南亚疟疾演化”(MESA)项目是由美国国立卫生研究院(NIH)资助的国际疟疾研究卓越中心(ICEMR)的一个项目。这个美印合作项目将研究疟原虫遗传多样性的起源及其在印度次大陆的选择。这方面的知识应该有助于更好地理解来自恶性疟原虫和间日疟原虫感染的意外疾病爆发和不可预测的疾病表现。在这两篇综述中的第一篇中,我们强调了印度的疟疾流行情况。特别是,我们提请注意不同人类寄生虫和不同媒介的分布变化、药物耐药性特征的变化以及多种临床表现形式。印度疟疾严重程度不均,通常归因于医疗保健可及性方面的巨大差异,以及国内和邻国之间的人口迁移。一些地区缺乏医疗保健的同时,也缺乏报告,这可能导致印度某些地区的疟疾流行和死亡数据出现扭曲。正在通过增加疾病控制资源、增加村级卫生工作者的参与以进行早期诊断和治疗以及在受影响最严重的地区可能开展新的公私伙伴关系活动来进行纠正,这些活动是国家疟疾控制计划的补充。第二篇伴随的综述提出了这样一种可能性,即除了医疗保健不平等之外,进化压力可能会以导致印度严重疾病的方式改变疟原虫,特别是在与缅甸接壤的印度东北部走廊。Narayanasamy 等人,2012 年。

相似文献

1
Malaria in South Asia: prevalence and control.
Acta Trop. 2012 Mar;121(3):246-55. doi: 10.1016/j.actatropica.2012.01.004. Epub 2012 Jan 8.
2
Malaria evolution in South Asia: knowledge for control and elimination.
Acta Trop. 2012 Mar;121(3):256-66. doi: 10.1016/j.actatropica.2012.01.008. Epub 2012 Jan 14.
3
Malaria in selected non-Amazonian countries of Latin America.
Acta Trop. 2012 Mar;121(3):303-14. doi: 10.1016/j.actatropica.2011.06.008. Epub 2011 Jul 1.
5
Malaria in India: the center for the study of complex malaria in India.
Acta Trop. 2012 Mar;121(3):267-73. doi: 10.1016/j.actatropica.2011.11.008. Epub 2011 Nov 28.
6
International Center of Excellence for Malaria Research for South Asia and Broader Malaria Research in India.
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):118-123. doi: 10.4269/ajtmh.22-0005.
7
Malaria in the Greater Mekong Subregion: heterogeneity and complexity.
Acta Trop. 2012 Mar;121(3):227-39. doi: 10.1016/j.actatropica.2011.02.016. Epub 2011 Mar 5.
8
Malaria in Uganda: challenges to control on the long road to elimination: I. Epidemiology and current control efforts.
Acta Trop. 2012 Mar;121(3):184-95. doi: 10.1016/j.actatropica.2011.03.004. Epub 2011 Mar 21.
9
Malaria elimination in India and regional implications.
Lancet Infect Dis. 2016 Oct;16(10):e214-e224. doi: 10.1016/S1473-3099(16)30123-2. Epub 2016 Aug 12.
10
Malaria control in Malawi: current status and directions for the future.
Acta Trop. 2012 Mar;121(3):212-7. doi: 10.1016/j.actatropica.2011.06.017. Epub 2011 Jul 8.

引用本文的文献

3
6
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery-An Update.
Adv Med. 2023 Mar 14;2023:5060665. doi: 10.1155/2023/5060665. eCollection 2023.
7
The Effect of Socioeconomic Factors and Indoor Residual Spraying on Malaria in Mangaluru, India: A Case-Control Study.
Int J Environ Res Public Health. 2021 Nov 12;18(22):11853. doi: 10.3390/ijerph182211853.
9
Comparison of polymerase chain reaction, microscopy, and rapid diagnostic test in malaria detection in a high burden state (Odisha) of India.
Pathog Glob Health. 2021 Jun;115(4):267-272. doi: 10.1080/20477724.2021.1893484. Epub 2021 Feb 26.

本文引用的文献

2
Malaria evolution in South Asia: knowledge for control and elimination.
Acta Trop. 2012 Mar;121(3):256-66. doi: 10.1016/j.actatropica.2012.01.008. Epub 2012 Jan 14.
3
Foreword. The international centers of excellence for malaria research.
Acta Trop. 2012 Mar;121(3):157. doi: 10.1016/j.actatropica.2011.07.009. Epub 2011 Jul 29.
4
Malaria-attributed death rates in India.
Lancet. 2011 Mar 19;377(9770):993; author reply 994-5. doi: 10.1016/S0140-6736(11)60381-4.
5
Malaria-attributed death rates in India.
Lancet. 2011 Mar 19;377(9770):993-4; author reply 994-5. doi: 10.1016/S0140-6736(11)60382-6.
6
Malaria-attributed death rates in India.
Lancet. 2011 Mar 19;377(9770):992-3; author reply 994-5. doi: 10.1016/S0140-6736(11)60380-2.
7
Malaria-attributed death rates in India.
Lancet. 2011 Mar 19;377(9770):991-2; author reply 994-5. doi: 10.1016/S0140-6736(11)60379-6.
8
Malaria-attributed death rates in India.
Lancet. 2011 Mar 19;377(9770):991; author reply 994-5. doi: 10.1016/S0140-6736(11)60378-4.
9
Defying malaria: Fathoming severe Plasmodium vivax disease.
Nat Med. 2011 Jan;17(1):48-9. doi: 10.1038/nm0111-48.
10
Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space.
Lancet Infect Dis. 2011 Jan;11(1):57-64. doi: 10.1016/S1473-3099(10)70214-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验